Importance Deficiency of adenosine deaminase 2 (DADA2) is a recessively inherited
disease characterized by systemic vasculitis, early-onset stroke, bone marrow failure, and/or …

Introduction Deficiency of adenosine deaminase 2 (DADA2) is a rare monogenic
autoinflammatory disease, whose clinical phenotype was expanded since the first cases …

Deficiency of adenosine deaminase type 2 (DADA2) was first described in 2014 as a
monogenic cause of polyartertitis nodosa (PAN), early onset lacunar stroke and livedo …

Though rare, stroke in infants and children is an important cause of mortality and chronic
morbidity in the pediatric population. Neuroimaging advances and implementation of …

Deficiency of human adenosine deaminase type 2 (DADA2) is a complex systemic
autoinflammatory disorder characterized by vasculopathy, immune dysregulation, and …

Vasculitides, characterized by inflammation and damage of blood vessels, encompass a
broad spectrum of diseases. They can occur with different pathophysiological mechanisms …

Deficiency of adenosine deaminase 2 (DADA2) is an inherited autosomal recessive disease
characterized by autoinflammation (recurrent fever), vasculopathy (livedo racemosa …

Abstract Purpose of Review To provide a comprehensive review of drugs and neoplastic,
infectious, autoinflammatory, and immunodeficiency diseases causing medium-to large …

Vaccines are a key weapon against the COVID-19 pandemic caused by SARS-CoV-2.
However, there are inter-individual differences in immune response to SARS-CoV-2 …

The deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease
caused by loss-of-function (LOF) mutations in the ADA2 gene and was first described in …